Results 301 to 310 of about 571,490 (310)

Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Anemia,Cancer,Kidney Failure, Chronic, Date of authorisation: 08/06/2001, Revision: 41, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes

Nature Medicine
Pardeep S Jhund, Alasdair Henderson, Meike Brinker   +2 more
exaly  

Human medicines European public assessment report (EPAR): Epoetin Alfa Hexal, epoetin alfa, Anemia,Kidney Failure, Chronic,Cancer, Date of authorisation: 27/08/2007, Revision: 20, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

New England Journal of Medicine
Katherine R Tuttle, Peter Rossing, George L Bakris   +2 more
exaly  

Multifactorial management of complex comorbidity followed by heart failure, chronic kidney disease and type 2 diabetes mellitus: the way to overcome missed opportunities

Heart
openaire   +2 more sources

Human medicines European public assessment report (EPAR): NeoRecormon, epoetin beta, Kidney Failure, Chronic,Anemia,Cancer,Blood Transfusion, Autologous, Date of authorisation: 16/07/1997, Revision: 28, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Capacity for the management of kidney failure in the International Society of Nephrology Africa region: report from the 2023 ISN Global Kidney Atlas (ISN-GKHA)

Kidney International Supplements
Elliot Koranteng Tannor, Yannick Nlandu, Peace Bagasha   +2 more
exaly  

Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Anemia,Blood Transfusion, Autologous,Kidney Failure, Chronic,Cancer, Date of authorisation: 18/12/2007, Revision: 23, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Anemia,Kidney Failure, Chronic,Cancer, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 22, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Abseamed, epoetin alfa, Anemia,Kidney Failure, Chronic,Cancer, Date of authorisation: 27/08/2007, Date of refusal: 18/06/2009, Revision: 21, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source